CGC

CANOPY GROWTH CORPORATION

CGC·138035704·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic

CGC (CANOPY GROWTH CORPORATION) is held by 64 institutional investors as of Q2 2026. Largest holders: Tidal Investments LLC ($8.7M), MORGAN STANLEY ($1.8M), LAZARD ASSET MANAGEMENT LLC ($1.8M). Net institutional sentiment: Mixed.

64
Holders
(7 Elite)
$23.8M
Total Value
55% (65)
Consensus
36 buying - 29 selling
13F: Insider & Congress: Updated regularly
CGC

Smart Money Verdict

View all
Loading verdict
Held by 64 funds
7 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 25, 2026 · Activists none · Congress none

InsiderGCGedeon ChristelleSellAug 24, 2026
InsiderSCStewart Thomas CarltonSellAug 24, 2026
InsiderYTYanofsky TheresaSell $16KSep 29, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.2M(+8.4%)$8.7M0.0%-62.00%
30
Decreased
1.9M(-1.2%)$1.8M0.0%-67.96%
0
Increased
1.8M(+2.2%)$1.8M0.0%-2.14%
26
Decreased
1.6M(-1.2%)$1.5M0.0%-26.27%
0
Increased
1.4M(+48.6%)$1.3M0.0%-18.54%
35
Increased
1.3M(+3.2%)$1.2M0.0%-21.39%
26
Increased
1.2M(+24.3%)$1.2M0.0%-27.83%
31
Increased
1.1M(+10.9%)$1M0.0%-2.68%
28
Increased
858,456(+6.0%)$816,0230.0%-3.55%
26
Increased
686,625(+34.5%)$667,8710.0%-93.01%
32
Increased
477,300(+37.2%)$658,6740.0%-79.37%
32
Decreased
500,707(-37.1%)$486,2270.0%-30.73%
0
Decreased
492,571(-43.2%)$470,5430.0%-36.16%
0
Unchanged
335,000$318,2500.0%-2.36%
0
Increased
279,724(+392.9%)$266,5370.0%+0.56%
37
Increased
167,285(+30.1%)$158,9200.0%-97.22%
19
Increased
153,500(+3.7%)$145,8250.0%-2.00%
23
Increased
127,191(+6.8%)$122,4030.0%-80.56%
24
New
96,765$91,9270.0%+8.95%
30
Increased
93,767(+6.3%)$90,6260.0%-91.51%
23

Showing 1-20 of 71

1 / 4
CGCCGCCANOPY GROWTH CORPORATION

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used